|
| Analyst
Scorecard | | Analyst: | Vaino, Andrew | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Roth Capital Partners LLC | Recommendation
Performance: | 
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| Not Avl.
|
17.7%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
BMRN
|
Biomarin Pharmaceutical Inc
|
|
18
| | | | |
CHTP
|
Chelsea Therapeutics Internation
|
|
5
| | | | |
HALO
|
Halozyme Therapeutics Inc
|
|
7
| | | | |
INFI
|
Infinity Pharmaceuticals Inc
|
|
6
| | | | |
MDVN
|
Medivation Inc
|
|
9
| | | | |
MITI
|
Micromet Inc
|
|
7
| | | | |
NGSX
|
Neurogesx Inc
|
|
4
| | | | |
SNTA
|
Synta Pharmaceuticals Corp
| 
|
5
| | | | |
SVNT
|
Savient Pharmaceuticals Inc.
|
|
9
| | | | |
TTHI
|
Transition Therapeutics Inc
|
|
2
| | | | |
VRUS
|
Pharmasset Inc
|
|
12
| | | |
| Other Stocks Covered
| |
Alnylam Pharmaceuticals Inc (ALNY), Clinical Data Inc (CLDA), Lpath Inc (LPTN.OB), Neurologix Inc (NRGX.OB), Prolor Biotech Inc (PBTH.OB), Senomyx Inc (SNMX)
|
| | |
|
|
|